Valorisation

• Sarnowski C, Ghanbari M, Bis JC, Logue M, Fornage M, Mishra A, et al. Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels. Commun Biol. 8 avr 2022;5(1):336.
   
• Rouanet A, Avila-Rieger J, Dugravot A, Lespinasse J, Stuckwisch R, Merrick R, et al. How Selection Over Time Contributes to the Inconsistency of the Association Between Sex/Gender and Cognitive Decline Across Cognitive Aging Cohorts. Am J Epidemiol. 19 févr 2022;191(3):441 52.
   
• Régy M, Dugravot A, Sabia S, Fayosse A, Mangin JF, Chupin M, Fischer C, Bouteloup V, Dufouil C, Chêne G, Paquet C, Hanseeuw B, Singh-Manoux A, Dumurgier J; MEMENTO cohort Study Group. Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study. Neuroimage. 2022 Feb 2;250:118966. doi: 10.1016/j.neuroimage.2022.118966. Epub ahead of print. PMID: 35122970.
   
• Mishra A, Duplaà C, Vojinovic D, Suzuki H, Sargurupremraj M, Zilhão NR, et al. Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate. Brain. 2 mai 2022;awab432.
   
• Grasset L, Proust-Lima C, Mangin JF, Habert MO, Dubois B, Paquet C, et al. Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort. Alzheimers Res Ther. 18 mai 2022;14(1):68.
   
• Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Delrieu J, et al. Benzodiazepine use and neuroimaging markers of Alzheimer’s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort. Neuropsychopharmacol. avr 2022;47(5):1114 20.

• Teipel SJ, Dyrba M, Vergallo A, Lista S, Habert MO, Potier MC, Lamari F, Dubois B, Hampel H, Grothe MJ. Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis. Front Aging Neurosci. 2021 Dec 22;13:748198. doi: 10.3389/fnagi.2021.748198. eCollection 2021.PMID: 35002673
   
• Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Delrieu J, Lebouvier T, Robert G, David R, Bulteau S, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, Barantin L, Andersson F, Cottier JP, Gissot V, El-Hage W, Camus V, Gohier B, Desmidt T; MEMENTO study group .Benzodiazepine use and neuroimaging markers of Alzheimer's disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort. Neuropsychopharmacology. 2021 Dec 10. doi: 10.1038/s41386-021-01246-5. Online ahead of print.PMID: 34893757
   
• Kühnel L, Bouteloup V, Lespinasse J, Chêne G, Dufouil C, Molinuevo JL, Raket LL; MEMENTO study group and the Alzheimer's Disease Neuroimaging Initiative. Personalized prediction of progression in pre-dementia patients based on individual biomarker profile: A development and validation study. Alzheimers Dement. 2021 Dec;17(12):1938-1949. doi: 10.1002/alz.12363. Epub 2021 Sep 28. PMID: 34581496.
   
• Gaubert S, Houot M, Raimondo F, Ansart M, Corsi MC, Naccache L, Sitt JD, Habert MO, Dubois B, De Vico Fallani F, Durrleman S, Epelbaum S; INSIGHT-preAD study group. A machine learning approach to screen for preclinical Alzheimer's disease. Neurobiol Aging. 2021 Sep;105:205-216. doi: 10.1016/j.neurobiolaging.2021.04.024. Epub 2021 May 4.PMID: 34102381
   
• Rouanet A, Avila-Rieger J, Dugravot A, Lespinasse J, Stuckwisch R, Merrick R, Anderson E, Long L, Helmer C, Jacqmin-Gadda H, Dufouil C, Judd S, Manly J, Sabia S, Gross A, Proust-Lima C. How Selection Over Time Contributes to the Inconsistency of the Association between Sex/Gender and Cognitive Decline across Cognitive Aging Cohorts. Am J Epidemiol. 2021 Sep 14:kwab227. doi: 10.1093/aje/kwab227. Online ahead of print.PMID: 34521111
   
• Frison E, Proust-Lima C, Mangin JF, Habert MO, Bombois S, Ousset PJ, Pasquier F, Hanon O, Paquet C, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Béjot Y, Belin C, Wallon D, Sauvee M, Beaufils E, Bourdel-Marchasson I, Jalenques I, Chupin M, Chêne G, Dufouil C; MEMENTO Cohort Study Group. Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort. Neurology. 2021 Aug 24;97(8):e836-e848. doi: 10.1212/WNL.0000000000012440. Epub 2021 Jul 1. PMID: 34210821; PMCID: PMC8397583.
   
• Chamberlain JD, Rouanet A, Dubois B, Pasquier F, Hanon O, Gabelle A, Ceccaldi M, Krolak-Salmon P, Béjot Y, Godefroy O, Wallon D, Gentric A, Chêne G, Dufouil C; Memento Study group. Investigating the association between cancer and the risk of dementia: Results from the Memento cohort. Alzheimers Dement. 2021Sep;17(9):1415-1421. doi: 10.1002/alz.12308. Epub 2021 Mar 3. PMID: 33656287; PMCID: PMC8518910.
   
• Penner G, Lecocq S, Chopin A, Vedoya X, Lista S, Vergallo A, Cavedo E, Lejeune FX, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's disease. PLoS One. 2021 Jan 4;16(1):e0243902. doi: 10.1371/journal.pone.0243902. eCollection 2021.PMID: 33395442

• Planche V, Bouteloup V, Mangin JF, Dubois B, Delrieu J, Pasquier F, Blanc F, Paquet C, Hanon O, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Habert MO, Fischer C, Chupin M, Béjot Y, Godefroy O, Wallon D, Sauvée M, Bourdel- Marchasson I, Jalenques I, Tison F, Chêne G, Dufouil C; the MEMENTO Study group. Clinical relevance of brain atrophy subtypes categorization in memory clinics. Alzheimers Dement. 2021 Apr;17(4):641-652. doi: 10.1002/alz.12231 . Epub 2020 Dec 15. PMID: 33325121.

• Baldacci F, Lista S, Manca ML, Chiesa PA, Cavedo E, Lemercier P, Zetterberg H, Blennow K, Habert MO, Potier MC, Dubois B, Vergallo A, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study. Alzheimers Res Ther. 2020 Nov 12;12(1):147. doi: 10.1186/s13195-020-00704-4 .PMID: 33183357 

• Cacciamani F, Sambati L, Houot M, Habert MO, Dubois B, Epelbaum S; INSIGHT-PreAD study group. Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD. Alzheimers Res Ther. 2020 Oct 14;12(1):129. doi: 10.1186/s13195-020-00700-8 . PMID: 33054821; PMCID: PMC7557018.

• Teipel SJ, Dyrba M, Chiesa PA, Sakr F, Jelistratova I, Lista S, Vergallo A, Lemercier P, Cavedo E, Habert MO, Dubois B, Hampel H, Grothe MJ; INSIGHT-preAD study group and for the Alzheimerś Disease Neuroimaging Initiative. In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease. Neurobiol Aging. 2020 Sep;93:98-108. doi: 10.1016/j.neurobiolaging.2020.03.011 . Epub 2020 Mar 17. PMID: 32291113.

• Vergallo A, Lista S, Lemercier P, Chiesa PA, Zetterberg H, Blennow K, Potier MC, Habert MO, Baldacci F, Cavedo E, Caraci F, Dubois B, Hampel H; INSIGHT-preAD study group and the Alzheimer Precision Medicine Initiative (APMI); INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers. Neurobiol Aging. 2020 Dec;96:22-32. doi: 10.1016/j.neurobiolaging.2020.07.009 . Epub 2020 Aug 17. PMID: 32920471.

• Vonk JMJ, Bouteloup V, Mangin JF, Dubois B, Blanc F, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Belin C, Rivasseau-Jonveaux T, Julian A, Sellal F, Magnin E, Chupin M, Habert MO, Chêne G, Dufouil C; MEMENTO cohort Study Group. Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia. Alzheimers Dement (Amst). 2020 Aug 5;12(1):e12066. doi: 10.1002/dad2.12066 . PMID: 32775598; PMCID: PMC7403823.

• Delabar JM, Ortner M, Simon S, Wijkhuisen A, Feraudet-Tarisse C, Pegon J, Vidal E, Hirschberg Y, Dubois B, Potier MC. Altered age-linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT-preAD study) with high brain amyloid load. Alzheimers Dement (N Y). 2020 Jul 2;6(1):e12046. doi: 10.1002/trc2.12046 . PMID: 32642550; PMCID: PMC7331462.

• Dauphinot V, Bouteloup V, Mangin JF, Vellas B, Pasquier F, Blanc F, Hanon O, Gabelle A, Annweiler C, David R, Planche V, Godefroy O, Rivasseau-Jonveaux T, Chupin M, Fischer C, Chêne G, Dufouil C, Krolak-Salmon P. Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohort. Alzheimers Dement (Amst). 2020 Jul 5;12(1):e12051. doi: 10.1002/dad2.12051. PMID: 32647745; PMCID: PMC7335902.

• Babiloni C, Lopez S, Del Percio C, Noce G, Pascarelli MT, Lizio R, Teipel SJ, González-Escamilla G, Bakardjian H, George N, Cavedo E, Lista S, Chiesa PA, Vergallo A, Lemercier P, Spinelli G, Grothe MJ, Potier MC, Stocchi F, Ferri R, Habert MO, Fraga FJ, Dubois B, Hampel H; INSIGHT-preAD Study Group. Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD study. Neurobiol Aging. 2020 Jun;90:43-59. doi: 10.1016/j.neurobiolaging.2020.01.012 . Epub 2020 Feb 1. PMID: 32111391

• Bauermeister S, Orton C, Thompson S, Barker RA, Bauermeister JR, Ben-Shlomo Y, Brayne C, Burn D, Campbell A, Calvin C, Chandran S, Chaturvedi N, Chêne G, Chessell IP, Corbett A, Davis DHJ, Denis M, Dufouil C, Elliott P, Fox N, Hill D, Hofer SM, Hu MT, Jindra C, Kee F, Kim CH, Kim C, Kivimaki M, Koychev I, Lawson RA, Linden GJ, Lyons RA, Mackay C, Matthews PM, McGuiness B, Middleton L, Moody C, Moore K, Na DL, O'Brien JT, Ourselin S, Paranjothy S, Park KS, Porteous DJ, Richards M, Ritchie CW, Rohrer JD, Rossor MN, Rowe JB, Scahill R, Schnier C, Schott JM, Seo SW, South M, Steptoe M, Tabrizi SJ, Tales A, Tillin T, Timpson NJ, Toga AW, Visser PJ, Wade-Martins R, Wilkinson T, Williams J, Wong A, Gallacher JEJ. The Dementias Platform UK (DPUK) Data Portal. Eur J Epidemiol. 2020 Jun;35(6):601-611. doi: 10.1007/s10654-020-00633-4 . Epub 2020 Apr 23.

• Chiesa PA, Cavedo E, Vergallo A, Lista S, Potier MC, Habert MO, Dubois B, Thiebaut de Schotten M, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease. Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30077-9. doi: 10.1016/j.jalz.2019.03.006 .

• Gagliardi G, Houot M, Cacciamani F, Habert MO, Dubois B, Epelbaum S; for ADNI; for the INSIGHT-preAD study group. The meta-memory ratio: a new cohort-independent way to measure cognitive awareness in asymptomatic individuals at risk for Alzheimer's disease. Alzheimers Res Ther. 2020 May 14;12(1):57. doi: 10.1186/s13195-020-00626-1 . PMID: 32408882; PMCID: PMC7222501.

• Chiesa PA, Houot M, Vergallo A, Cavedo E, Lista S, Potier MC, Zetterberg H, Blennow K, Vanmechelen E, De Vos A, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Association of brain network dynamics with plasma biomarkers in subjective memory complainers. Neurobiol Aging. 2020 Apr;88:83-90. doi: 10.1016/j.neurobiolaging.2019.12.017 . Epub 2019 Dec 23. PMID: 32087948.

• Janssen O, Vos SJB, García-Negredo G, Tochel C, Gustavsson A, Smith M, Ly A, Nelson M, Baldwin H, Sudlow C, Bexelius C, Jindra C, Vaci N, Bauermeister S, Gallacher J, Ponjoan A, Dufouil C, Garre Olmo J, Pedersen L, Skoog I, Hottgenroth A, Visser PJ, van der Lei J, Diaz C. Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube. Alzheimers Dement. 2020 Mar;16(3):461-471. doi: 10.1016/j.jalz.2019.09.087 . Epub 2020 Jan 6. PMID: 32157788.

• Cavedo E, Lista S, Houot M, Vergallo A, Grothe MJ, Teipel S, Zetterberg H, Blennow K, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group, Alzheimer Precision Medicine Initiative. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Neurology. 2020 Jan 7;94(1):e30-e41. doi: 10.1212/WNL.0000000000008696. Epub 2019 Dec 4. PMID: 31801830.

• Gagliardi G, Epelbaum S, Houot M, Bakardjian H, Boukadida L, Revillon M, Dubois B, Dalla Barba G, La Corte V; INSIGHT-preAD study group. Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD). J Alzheimers Dis. 2019;70(3):811-824. doi: 10.3233/JAD-180966 .PMID: 31282413

• Villeneuve SC, Houot M, Cacciamani F, Verrijp M, Dubois B, Sikkes S, Epelbaum S; MEMENTO study group and the INSIGHT-preAD study group. Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease. Alzheimers Dement (N Y). 2019 Oct 8;5:553-562. doi: 10.1016/j.trci.2019.08.009 . PMID: 31650012; PMCID: PMC6804616.

• Xicota L, Ichou F, Lejeune FX, Colsch B, Tenenhaus A, Leroy I, Fontaine G, Lhomme M, Bertin H, Habert MO, Epelbaum S, Dubois B, Mochel F, Potier MC; INSIGHT study group. Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study. EBioMedicine. 2019 Sep;47:518-528. doi: 10.1016/j.ebiom.2019.08.051 . Epub 2019 Sep 3. PMID: 31492558; PMCID: PMC6796577.

• Vergallo A, Mégret L, Lista S, Cavedo E, Zetterberg H, Blennow K, Vanmechelen E, De Vos A, Habert MO, Potier MC, Dubois B, Neri C, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. Alzheimers Dement. 2019 Jun;15(6):764-775. doi: 10.1016/j.jalz.2019.03.009 . Epub 2019 May 18. PMID: 31113759.

• Taillard J, Sagaspe P, Berthomier C, Brandewinder M, Amieva H, Dartigues JF, Rainfray M, Harston S, Micoulaud-Franchi JA, Philip P. Non-REM Sleep Characteristics Predict Early Cognitive Impairment in an Aging Population. Front Neurol. 2019 Mar 13;10:197. doi: 10.3389/fneur.2019.00197 . PMID: 30918496; PMCID: PMC6424890.

• Pase MP, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, DeCarli C, Chêne G, Dufouil C, Seshadri S. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes. JAMA Neurol. 2019 May 1;76(5):598-606. doi: 10.1001/jamaneurol.2018.4666 . PMID: 30830207; PMCID: PMC6515589.

• Sakr FA, Grothe MJ, Cavedo E, Jelistratova I, Habert MO, Dyrba M, Gonzalez-Escamilla G, Bertin H, Locatelli M, Lehericy S, Teipel S, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study. Alzheimers Res Ther. 2019 Jan 31;11(1):15. doi: 10.1186/s13195-019-0466-3 . PMID: 30704537; PMCID: PMC6357385.

• Chiesa PA, Cavedo E, Grothe MJ, Houot M, Teipel SJ, Potier MC, Habert MO, Lista S, Dubois B, Hampel H; INSIGHT-preAD Study Group and the Alzheimer Precision Medicine Initiative (APMI). Relationship between Basal Forebrain Resting-State Functional Connectivity and Brain Amyloid-β Deposition in Cognitively Intact Older Adults with Subjective Memory Complaints. Radiology. 2019 Jan;290(1):167-176. doi: 10.1148/radiol.2018180268 . Epub 2018 Oct 23. PMID: 30351255.

• Vergallo A, Bun RS, Toschi N, Baldacci F, Zetterberg H, Blennow K, Cavedo E, Lamari F, Habert MO, Dubois B, Floris R, Garaci F, Lista S, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Association of cerebrospinal fluid α-synuclein with total and phospho- tau(181) protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers. Alzheimers Dement. 2018 Dec;14(12):1623- 1631. doi: 10.1016/j.jalz.2018.06.3053 . Epub 2018 Jul 26. PMID: 30055132.

• Cavedo E, Chiesa PA, Houot M, Ferretti MT, Grothe MJ, Teipel SJ, Lista S, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group; Alzheimer Precision Medicine Initiative (APMI). Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints. Alzheimers Dement. 2018 Sep;14(9):1204-1215. doi: 10.1016/j.jalz.2018.05.014 . Epub 2018 Jul 7. PMID: 30201102.

• Teipel SJ, Cavedo E, Lista S, Habert MO, Potier MC, Grothe MJ, Epelbaum S, Sambati L, Gagliardi G, Toschi N, Greicius MD, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study. Alzheimers Dement. 2018 Sep;14(9):1126-1136. doi: 10.1016/j.jalz.2018.04.004 . Epub 2018 May 21. PMID: 29792873.

• Epelbaum S, Bouteloup V, Mangin JF, La Corte V, Migliaccio R, Bertin H, Habert MO, Fischer C, Azouani C, Fillon L, Chupin M, Vellas B, Pasquier F, Dartigues JF, Blanc F, Gabelle A, Ceccaldi M, Krolak-Salmon P, Hugon J, Hanon O, Rouaud O, David R, Chêne G, Dubois B, Dufouil C. Neural correlates of episodic memory in the Memento cohort. Alzheimers Dement (N Y). 2018 May 22;4:224-233. doi: 10.1016/j.trci.2018.03.010 . PMID: 29955665; PMCID: PMC6021546.

• Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, Houot M, Lista S, Cacciamani F, Potier MC, Bertrand A, Lamari F, Benali H, Mangin JF, Colliot O, Genthon R, Habert MO, Hampel H; INSIGHT-preAD study group. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2 . Epub 2018 Feb 27. Erratum in: Lancet Neurol. 2018 Apr 25;: PMID: 29500152.

• Habert MO, Bertin H, Labit M, Diallo M, Marie S, Martineau K, Kas A, Causse-Lemercier V, Bakardjian H, Epelbaum S, Chételat G, Houot M, Hampel H, Dubois B, Mangin JF; INSIGHT-AD study group. Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds. Ann Nucl Med. 2018 Feb;32(2):75-86. doi: 10.1007/s12149-017-1221-0 . Epub 2017 Dec 7. PMID: 29218458.

• Mendes A, Tezenas du Montcel S, Levy M, Bertrand A, Habert MO, Bertin H, Dubois B, Epelbaum S; INSIGHT-PreAD study group. Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers. Dement Geriatr Cogn Disord. 2018;45(5-6):272-281. doi: 10.1159/000489007 . Epub 2018 Jun 28. PMID: 29953971.

• Teipel S, Bakardjian H, Gonzalez-Escamilla G, Cavedo E, Weschke S, Dyrba M, Grothe MJ, Potier MC, Habert MO, Dubois B, Hampel H; INSIGHT-preAD study group. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints. Neuroimage Clin. 2017 Oct 29;17:435-443. doi: 10.1016/j.nicl.2017.10.031. PMID: 29159056; PMCID: PMC5684495.

• Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G, Dauphinot L, Gonzalez-Escamilla G, Potier MC, Bertin H, Habert MO, Dubois B, Hampel H; INSIGHT-preAD study group. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol Aging. 2017 Sep;57:143-152. doi: 10.1016/j.neurobiolaging.2017.05.016 . Epub 2017 May 31. PMID: 28646687.

• Cacciamani F, Tandetnik C, Gagliardi G, Bertin H, Habert MO, Hampel H, Boukadida L, Révillon M, Epelbaum S, Dubois B; INSIGHT-PreAD study group. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease. J Alzheimers Dis. 2017;59(2):753-762. doi: 10.3233/JAD-170399. PMID: 28671134.

• Dufouil C, Dubois B, Vellas B, Pasquier F, Blanc F, Hugon J, Hanon O, Dartigues JF, Harston S, Gabelle A, Ceccaldi M, Beauchet O, Krolak-Salmon P, David R, Rouaud O, Godefroy O, Belin C, Rouch I, Auguste N, Wallon D, Benetos A, Pariente J, Paccalin M, Moreaud O, Hommet C, Sellal F, Boutoleau-Bretonniére C, Jalenques I, Gentric A, Vandel P, Azouani C, Fillon L, Fischer C, Savarieau H, Operto G, Bertin H, Chupin M, Bouteloup V, Habert MO, Mangin JF, Chêne G; MEMENTO cohort Study Group. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Alzheimers Res Ther. 2017 Aug 29;9(1):67. doi: 10.1186/s13195-017-0288-0. PMID: 28851447; PMCID: PMC5576287.

• Kaaouana T, Bertrand A, Ouamer F, Law-Ye B, Pyatigorskaya N, Bouyahia A, Thiery N, Dufouil C, Delmaire C, Dormont D, de Rochefort L, Chupin M. Improved cerebral microbleeds detection using their magnetic signature on T2*-phase-contrast: A comparison study in a clinical setting. Neuroimage Clin. 2016 Aug 9;15:274-283. doi: 10.1016/j.nicl.2016.08.005. PMID: 28560152; PMCID: PMC5435598.